MATRIX METALLOPROTEINASE-2 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 EXPRESSION IN PEDIATRIC TUMOR-CELLS - EFFECTS OF TUMOR-CELL PROLIFERATION MODULATORS ON GELATINOLYTIC ACTIVITY

被引:18
作者
DEVEAS, RG
SCHWEIGERER, L
MEDINA, MA
机构
[1] UNIV MALAGA,FAC CIENCIAS,BIOQUIM & BIOL MOLEC LAB,E-29071 MALAGA,SPAIN
[2] CHILDRENS UNIV HOSP,DIV HEMATOL ONCOL,D-69120 HEIDELBERG,GERMANY
关键词
72-KDA GELATINASE; TYPE IV COLLAGENASE; MMP-2; TIMP-2; NEUROBLASTOMA; OSTEOSARCOMA; RHABDOMYOSARCOMA; GENISTEIN;
D O I
10.1007/BF01209593
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have examined the expression of 72-kDa gelatinase/type IV collagenase or matrix metalloproteinase-2 (MMP-2) and its inhibitor, tissue inhibitor of metalloproteinase-2 (TIMP-2), in various cell lines derived from paediatric tumours. In a neuroblastoma model system of tumour progression, the expression level of MMP-2 mRNA was higher in the more malignant cell line. Surprisingly, MMP-2 was not expressed in the highly malignant rhabdomyosarcoma A-204 cell line. TIMP-2 showed higher expression levels in the 007 and U-2OS tumour cell lines than in the more malignant ones, WAC2 and A-204 cells. We have also determined the effect of some tumour cell proliferation modulators on gelatinolytic activity. While basic fibroblast growth factor and retinoic acid produced no apparent change in gelatinolytic activity, genistein induced in partial inhibition of gelatinolytic activity.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 50 条
  • [41] Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells
    Kumi-Diaka, J. K.
    Hassanhi, M.
    Merchant, K.
    Horman, Vanessa
    JOURNAL OF MEDICINAL FOOD, 2006, 9 (04) : 491 - 497
  • [42] Matrix metalloproteinase-2,-9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients
    Hsiao, Yu-Feng
    Yang, Li-Chiu
    Chou, Yu-Shian
    Ho, Ya-Ping
    Lin, Ying-Chu
    Ho, Kun-Yen
    Wu, Yi-Min
    Tsai, Chi-Cheng
    JOURNAL OF DENTAL SCIENCES, 2016, 11 (04) : 411 - 418
  • [43] Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue
    Zhou, C. X.
    Gao, Y.
    Johnson, N. W.
    Gao, J.
    AUSTRALIAN DENTAL JOURNAL, 2010, 55 (04) : 385 - 389
  • [44] The Contribution of Tissue Inhibitor of Metalloproteinase-2 Genotypes to Breast Cancer Risk in Taiwan
    Wang, Yun-Chi
    He, Jie-Long
    Tsai, Chung-Lin
    Tzeng, Huey-En
    Chang, Wen-Shin
    Pan, Shih-Han
    Chen, Li-Hsiou
    Su, Chen-Hsien
    Lin, Jiunn-Cherng
    Hung, Chih-Chiang
    Bau, Da-Tian
    Tsai, Chia-Wen
    LIFE-BASEL, 2024, 14 (01):
  • [45] Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma
    Wajner, Simone Magagnin
    Capp, Clarissa
    Brasil, Beatriz Assis
    Meurer, Luise
    Maia, Ana Luiza
    ONCOLOGY LETTERS, 2014, 7 (03) : 731 - 737
  • [46] Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer
    Nakopoulou, L
    Katsarou, S
    Giannopoulou, I
    Alexandrou, P
    Tsirmpa, I
    Panayotopoulou, E
    Mavrommatis, J
    Keramopoulos, A
    MODERN PATHOLOGY, 2002, 15 (01) : 26 - 34
  • [47] Diagnostic Evaluation of Apoptosis Inhibitory Gene and Tissue Inhibitor Matrix Metalloproteinase-2 in Patients with Bladder Cancer
    Eissa, Sanaa
    Shabayek, Marwa I.
    Ismail, Manal F.
    El-Allawy, Raouf M.
    Hamdy, Mohamed A.
    IUBMB LIFE, 2010, 62 (05) : 394 - 399
  • [48] Hyperphagia and Leptin Resistance in Tissue Inhibitor of Metalloproteinase-2 Deficient Mice
    Stradecki, H. M.
    Jaworski, D. M.
    JOURNAL OF NEUROENDOCRINOLOGY, 2011, 23 (03) : 269 - 281
  • [49] Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells
    Kato, Y
    Yamashita, T
    Ishikawa, M
    ONCOLOGY REPORTS, 2002, 9 (03) : 565 - 569
  • [50] Increased Circulating Tissue Inhibitor of Metalloproteinase-2 Is Associated With Resistant Hypertension
    Sabbatini, Andrea R.
    Barbaro, Natalia R.
    de Faria, Ana Paula
    Modolo, Rodrigo
    Ritter, Alessandra Mileni V.
    Pinho, Claudio
    Amorim, Rivadavio Fernandes Batista
    Fontana, Vanessa
    Moreno, Heitor
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (10) : 969 - 975